Therapeutic Regimens on the Incidence of New Relapses
- Alibaz-Oner, F
- Karadeniz, A
- Yilmaz, S
- Balkarli, A
- Kimyon, G
- Yazici, A
- Cinar, M
- Yildiz, F
- Bilge, SY
- Bilgin, E
- Coskun, BN
- Omma, A
- Cetin, GY
- Cagatay, Y
- Karaaslan, Y
- Sayarlioglu, M
- Pehlivan, Y
- Kalyoncu, U
- Karadag, O
- Kasifoglu, T
- Erken, E
- Pay, S
- Cefle, A
- Kisacik, B
- Onat, AM
- Cobankara, V
- Direskeneli, H
DOIAbstract
Vascular involvement is one of the major causes of mortality and morbidity in Behcet disease (BD). There are no controlled studies for the management of vascular BD (VBD), and according to the EULAR recommendations, only immunosuppressive (IS) agents are recommended. In this study, we aimed to investigate the therapeutic approaches chosen by Turkish physicians during the initial event and relapses of VBD and the association of different treatment options with the relapses retrospectively.Patients with BD (n = 936, female/male: 347/589, mean age: 37.6 +/- 10.8) classified according to ISG criteria from 15 rheumatology centers in Turkey were included. The demographic data, clinical characteristics of the first vascular event and relapses, tre...
Add to ORKG